Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by KERA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KERA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The surprising new science of A.D.H.D.

46:09
 
Share
 

Manage episode 482787582 series 2164084
Content provided by KERA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KERA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

A.D.H.D is a fairly common diagnosis, but some researchers are wondering if we should start taking a more nuanced approach to treatment. Paul Tough is a contributing writer for The New York Times Magazine, and he joins host Krys Boyd to talk about why A.D.H.D. might be experienced by anyone at a given time and might not be a permanent diagnosis, and why doctors are rethinking standard stimulant medications. His article is “Have We Been Thinking About A.D.H.D. All Wrong?”

Learn about your ad choices: dovetail.prx.org/ad-choices
  continue reading

2138 episodes

Artwork

The surprising new science of A.D.H.D.

KERA's Think

593 subscribers

published

iconShare
 
Manage episode 482787582 series 2164084
Content provided by KERA. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KERA or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

A.D.H.D is a fairly common diagnosis, but some researchers are wondering if we should start taking a more nuanced approach to treatment. Paul Tough is a contributing writer for The New York Times Magazine, and he joins host Krys Boyd to talk about why A.D.H.D. might be experienced by anyone at a given time and might not be a permanent diagnosis, and why doctors are rethinking standard stimulant medications. His article is “Have We Been Thinking About A.D.H.D. All Wrong?”

Learn about your ad choices: dovetail.prx.org/ad-choices
  continue reading

2138 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play